Loading patent…
AssigneeIndustry-Academic Cooperation Foundation, Yonsei University
InventorsHo Jeong KWON, Jung Hwa CHANG
Estimating the term…
The present invention relates to a mitochondrial UQCRB mutant cell line expressing the UQCRB mutant protein. The present invention is directed to a novel research method for UQCRB activity evaluation using a novel mitochondrial UQCRB mutant cell line, and provides a method for anticancer activity evaluation, a method for angiogenesis inhibitory activity evaluation, and a method for screening a UQCRB activity inhibitor. In particular, the cell line of the present invention is a novel cell line having cell proliferative and angiogenesis inducing activities, and provides a method for screening an angiogenesis inhibitor or an anticancer material through the UQCRB activity inhibitory mechanism, and thus can be applied in the development of therapeutic agents against angiogenesis or mitochondria-mediated diseases and various cancers.
A mitochondrial ubiquinol-cytochrome c reductase binding protein (UQCRB) mutant animal cell line expressing a UQCRB mutant protein.
A method for anticancer activity evaluation, the method comprising:
A method for angiogenesis inhibitory activity evaluation, the method comprising:
A method for screening a UQCRB activity inhibitor, the method comprising:
Dependencies are inferred from the claim text.